NIH Data Management and Sharing Plan 2026: What the New Format Actually Requires
On May 25, 2026, NIH flipped a switch. Applications submitted on or after that date must use the new 2026 pilot Data Management and Sharing (DMS) Plan format announced in NOT-OD-26-046 — not the six-element structure most researchers have been using since the policy launched in January 2023. The new format is simpler, but "simpler" still requires decisions that will affect both your application and how you actually run the project.
Table of Contents
- What Changed on May 25, 2026 and Why NIH Did It
- The 2023 Policy vs. the 2026 Format: What Stayed, What Shifted
- The New Format: Three Questions and What They're Actually Asking
- Choosing a Data Repository: The Decision That Shapes Everything Else
- Budgeting for Data Sharing Without Overcomplicating the Justification
- What Reviewers and Program Officers Actually Notice
- Frequently Asked Questions
What Changed on May 25, 2026 and Why NIH Did It
NIH's 2023 Data Management and Sharing Policy was, by most accounts, well-intentioned but burdensome in practice. The six-element structure required researchers to address data types, related tools and software, standards, preservation timelines, access controls, and oversight mechanisms — all in a two-page attachment that most applicants had never written before the policy launched. Feedback from the extramural community was consistent: the format prompted repetitive, hedged language that satisfied the letter of the requirement without meaningfully advancing data sharing in practice.
NOT-OD-26-046, published in spring 2026, announced a pilot simplification. Starting with applications due on or after May 25, 2026, the DMS Plan format page is restructured around three core yes/no questions about sharing commitments, with narrative space for explaining how you'll carry them out. NIH framed this explicitly as a pilot and said it will evaluate whether additional changes are needed over the following year. That last point matters: the format will likely evolve again, which means another transition is probable before the policy fully matures.
If your next application has a due date before May 25, 2026, you can use either the old or new format — NIH accepted both during the transition window. If you're submitting after that date, you're on the new format. This guide covers the new one, and what you actually need to decide before you write it.
The 2023 Policy vs. the 2026 Format: What Stayed, What Shifted
The most important thing to understand about the 2026 change is what did not change. The underlying 2023 DMS Policy is still fully in effect. All researchers submitting applications for projects that generate scientific data are still required to plan for sharing that data. The policy's definition of "scientific data" covers processed data that supports published findings, not every raw file you produce in the lab. If you qualified as exempt from the policy before May 2026 because your project won't generate shareable data, you still qualify as exempt. The new format doesn't expand the scope of who needs to comply.
What shifted is the structure of the document itself. The old format asked you to describe six elements in narrative form, and most researchers spent considerable space restating obvious facts — yes, we will use validated standard formats when they exist. The new format is organized around commitments you can affirm or note exceptions to. This is a fundamentally different framing: instead of describing your practices, you're making attestations, and the narrative space is reserved for explaining how you'll meet each commitment or why a specific exception applies.
In practical terms, a well-executed 2026 DMS plan can be shorter and more direct than its 2023 predecessor. But "shorter" does not mean "generic." Plans that attract program officer questions are still the ones that read as copy-paste boilerplate — vague repository choices, unspecified timelines, or missing justification for a controlled-access approach. The new format reduces the amount of required language; it doesn't reduce the need to think through your actual sharing approach before you write.
The New Format: Three Questions and What They're Actually Asking
The 2026 pilot format centers on three yes/no questions. Each one sounds simple and is not.
Question 1 — Maximum Appropriate Sharing
Will there be maximum appropriate sharing of the scientific data underlying peer-reviewed publications and other findings? The word "appropriate" is doing real work here. NIH recognizes that some data can't be shared openly — human subjects data with consent restrictions, data covered by a data use agreement, proprietary data from industrial collaborators. If you answer yes, you're committing to share everything that legally and ethically can be shared. If you answer no, you need to briefly explain what constraints apply. "No" is an acceptable answer when the reason is legitimate; reviewers understand that controlled-access is sometimes the right approach.
Question 2 — Timing of Sharing
Will the scientific data underlying peer-reviewed publications be shared by the time of publication, or — for other findings — by the end of the period of performance? The default expectation is data-with-publication. This is the tightest timing requirement in the policy, and it's one that many researchers underestimate when they write their DMS plan during the application phase. If you plan to publish from Aim 1 data in year 2, that data should be in a repository by the time the paper is accepted. Your plan should say so explicitly, not leave it implied.
Question 3 — Duration of Availability
Will shared data be made available for at least as long as required by applicable repository policies or journal policies? This is largely a matter of repository selection. If you choose a repository that retains data indefinitely, like NIH-designated repositories, you can answer yes without much explanation. If you choose a repository with a shorter default retention window, you need to confirm you understand that constraint and explain any extension plan. The practical implication: pick your repository before you write the plan, not after.
After the three questions, the format includes a narrative section where you describe how you'll carry out the commitments — repository name, data format, estimated timing, any access controls, and how data sharing costs are budgeted. Think of this as the "show your work" section. A plan that answers all three questions "yes" but leaves the narrative blank is incomplete and will likely generate a Just-In-Time request or a pre-award negotiation.
Choosing a Data Repository: The Decision That Shapes Everything Else
Repository selection is the most consequential decision in your DMS plan, and many researchers treat it as an afterthought. The repository you choose determines your retention timeline (answering question 3), your access structure (relevant to question 1), and your likely data curation burden once the project is funded. Getting it wrong doesn't disqualify your application, but it can create compliance headaches during the award.
NIH maintains a list of NIH-supported repositories and a separate list of generalist repositories. For most basic science applications, the right starting point is a domain-specific NIH-supported repository: dbGaP for human genomics data, GEO for gene expression, SRA for sequencing data, and so on. These repositories are pre-approved as meeting NIH's standards, their retention policies satisfy question 3 by default, and reviewers recognize them immediately. If your data type doesn't fit a domain-specific repository, generalist repositories like Zenodo, Dryad, or Figshare are acceptable as long as you confirm they meet the retention requirement.
Two situations warrant more careful thought. First, if any of your data involves human subjects, your repository choice intersects with your IRB protocol and informed consent language. If your consent form doesn't explicitly cover data sharing in a public or controlled-access repository, you may need to either use a controlled-access repository like dbGaP's controlled tier, or plan a consent amendment before depositing data. Worth resolving before submission, not after. Second, if you're generating data in collaboration with industry partners, check whether your agreement restricts data sharing — and if so, document that restriction clearly in question 1 and the narrative. Silence on this point is a compliance risk that surfaces at the worst time.
Budgeting for Data Sharing Without Overcomplicating the Justification
Data sharing costs are allowable as direct costs under the 2023 DMS Policy and remain so under the 2026 format. NIH has been consistent on this point since the policy launched: you can budget for data curation, format conversion, metadata documentation, repository submission fees, and related personnel time. You don't have to hide these costs in a miscellaneous line or absorb them from other budget categories.
That said, the justification needs to be specific to survive budget review. "Data sharing costs: $5,000/year" without further explanation is exactly the kind of line that gets flagged during pre-award review. A more defensible approach is to identify the specific activity — for example, a research coordinator spending approximately five percent effort in years three and four on data curation and submission — and connect it to the timing commitment you described in question 2. If your plan says data will be deposited with each publication, reviewers can follow the logic and the cost is proportionate.
For modular budget applications, you don't need to justify individual line items in the same detail, but the budget narrative should mention that data sharing costs are included. Leaving the DMS plan silent on resources while budgeting for them creates a mismatch that a careful reviewer will note. The fix is easy: one sentence in the budget narrative and one sentence in the DMS plan narrative pointing to each other.
What Reviewers and Program Officers Actually Notice
DMS plans are not scored using a dedicated review criterion. They're assessed as part of the Resource Sharing Plan requirement and marked as acceptable or not acceptable. "Not acceptable" can delay your award, but an acceptable DMS plan doesn't boost your impact score. This asymmetry shapes how most reviewers read these plans: they're looking for red flags, not for opportunities to reward good data stewardship.
The red flags that come up most often are a plan that names a repository as TBD, a plan with no mention of timing, a plan that checks yes on question 1 but proposes only controlled-access sharing without justification, and a plan where the budget section and the DMS plan are inconsistent with each other. That last one is surprisingly common in multi-PI applications where the budget is written by one person and the DMS plan by another.
Repository listed as "TBD" or left vague
Pick an actual repository before you submit. Even if your domain's data doesn't fit a specialized NIH repository cleanly, commit to one generalist option and confirm it meets the retention requirement. "TBD" reads as unprepared and generates a pre-award negotiation on a point that should be trivial to resolve at the application stage.
Timing vague beyond "end of award"
If any of your aims are likely to produce publications, say when the associated data will be deposited — ideally at the time of publication or within a stated window. A plan that only references the end of the performance period looks like it's pushing the sharing obligation as far into the future as possible, which is not the posture NIH is looking for.
Human subjects data with no mention of consent coverage
If your project involves identifiable or potentially re-identifiable human data, your plan must address whether your IRB protocol and consent language cover repository deposit. If they don't yet, say so and describe how you'll resolve it. Silence on this point is a pre-award hold that almost always surfaces after the score is already in hand.
Frequently Asked Questions
Does the 2026 format change apply to all grant types?
The 2026 pilot format applies to applications subject to the 2023 DMS Policy — which covers most research grant mechanisms, including R01, R21, K awards, and F awards. Applications that were already exempt from the DMS Policy remain exempt from the new format as well. Conference grants and certain training mechanisms generally don't require a DMS plan; that hasn't changed. When in doubt, check the specific NOFO or parent announcement for your mechanism.
What if my data is sensitive or requires controlled access?
Controlled-access data sharing is explicitly anticipated in the new format. If you answer "no" or "partial" to question 1 because of privacy or consent constraints, provide a brief explanation and name the repository you'll use for controlled-access deposit, such as dbGaP. NIH expects applicants to share as much as is appropriate — controlled access is not a mechanism for avoiding sharing, it's a mechanism for sharing responsibly when open deposit isn't possible.
Can I reuse a DMS plan from a previous submission?
You can't directly reuse a 2023-format plan for a submission due on or after May 25, 2026. The form page itself has changed, and ASSIST will expect the new format. More practically, even if you could reuse the text, it's worth reviewing whether your repository choice, timing commitments, and budget are still accurate for the new project. A resubmission or renewal is a good opportunity to tighten the plan rather than carry forward language that was hedged the first time around.
Is NIH likely to update the format again before the pilot ends?
Possibly. NOT-OD-26-046 described this as a pilot with explicit plans for evaluation over the following year. The DMS Policy landscape has been in continuous motion since 2021, and it would be reasonable to expect at least one more notice before the pilot period closes. Check the NIH Extramural Nexus and grants.nih.gov for new notices before each submission cycle — the format could shift again, and a guide written months earlier may not reflect the current requirements.
Scope Your Research Area Before Writing the DMS Plan
The right repository choice and sharing strategy depend partly on what domain your project sits in and what other funded projects in your area are doing. The tools below help you explore that context before you commit to a specific approach.
Related Reading
Explore more resources to enhance your NIH funding knowledge
NIH Biographical Sketch Common Form 2026: SciENcv, ORCID, and Avoiding ASSIST Errors
NIH made the Biographical Sketch Common Form mandatory as of May 8, 2026. Covers what changed, the SciENcv workflow, and the three submission errors tripping up teams right now.
NIH Just-In-Time Request: What It Means and How to Respond Strategically
A practical guide to the NIH Just-In-Time (JIT) request — what the request signals, what documents to prepare, and the strategic decisions that matter most before you submit.
The Complete Guide to the NIH Grant Application Process
A step-by-step guide to NIH grant planning, writing, submission, peer review, and post-award management for researchers building a competitive application.
NIH Parent Announcements in 2026: Grant Strategy for the Simpler NOFO Landscape
NIH cut institute-specific FOAs in 2026 and shifted to broad parent announcements. Covers what changed and how to position an investigator-initiated application.
Trust & Transparency
How this content is reviewed before it goes live
NIH Grant Explorer combines public NIH records with editorial interpretation. We publish the review structure, methodology, and correction pathways so readers can judge the value of a guide or chart for themselves.
When a topic turns into an official policy question, we point readers back to NIH rather than pretending an independent site can replace the underlying federal guidance.
Contributors & Review Desks
See how data, strategy, and career-focused pages are reviewed.
Editorial Guidelines
How we source, update, and correct articles and tool explanations.
Data & Methodology
Refresh cadence, public-source coverage, and chart caveats.
Corrections & Contact
Send corrections, feedback, or contributor inquiries.